Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) General Information

Description

A portfolio of oncology programs. The portfolio consists of a skin-directed HDAC inhibitor and bivalent SMAC mimetic, used in the treatment of cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 343 Phoenixville Pike
  • Malvern, PA 19355
  • United States
Primary Industry
Other Healthcare Technology Systems
Acquirer
Vertical(s)
Corporate Office
  • 343 Phoenixville Pike
  • Malvern, PA 19355
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs)‘s full profile, request access.

Request a free trial

Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs)‘s full profile, request access.

Request a free trial

Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) FAQs

  • Where is Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) headquartered?

    Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) is headquartered in Malvern, PA.

  • What industry is Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) in?

    Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs)’s primary industry is Other Healthcare Technology Systems.

  • Is Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) a private or public company?

    Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) is a Private company.

  • What is the current valuation of Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs)?

    The current valuation of Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) is .

  • What is Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs)’s current revenue?

    The current revenue for Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) is .

  • Who are Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs)’s investors?

    TetraLogic Pharmaceuticals has invested in Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs).

  • When was Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) acquired?

    Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) was acquired on 29-Dec-2016.

  • Who acquired Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs)?

    Tetralogic Pharmaceuticals (Portfolio of Clinical Stage Oncology Programs) was acquired by Medivir.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process